Comprehensive surgical staging for endometrial cancer.

Bunja Rungruang, Alexander B Olawaiye
Author Information
  1. Bunja Rungruang: Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine Pittsburgh, PA.

Abstract

Despite a shift from clinical to surgical staging of endometrial cancer in 1988, performance of comprehensive surgical staging for clinically early-stage endometrial cancer remains controversial. Low-, intermediate-, and high-risk groups have been defined pathologically. Herein, we describe the risks and benefits of comprehensive surgical staging. Comprehensive surgical staging is encouraged in high-risk histologies, whereas a method of triage should be used to determine who among the low-grade endometrioid histology may benefit from comprehensive staging.

Keywords

References

  1. Gynecol Oncol. 2010 Oct;119(1):60-4 [PMID: 20638109]
  2. Cancer. 1987 Oct 15;60(8 Suppl):2035-41 [PMID: 3652025]
  3. Am J Obstet Gynecol. 1990 Feb;162(2):418-23; discussion 423-6 [PMID: 2309824]
  4. Lancet. 2010 Apr 3;375(9721):1165-72 [PMID: 20188410]
  5. Cancer. 2006 Oct 15;107(8):1823-30 [PMID: 16977653]
  6. Gynecol Oncol. 2004 Mar;92(3):744-51 [PMID: 14984936]
  7. Gynecol Oncol. 1995 Jan;56(1):29-33 [PMID: 7821843]
  8. J Clin Oncol. 2005 Jun 1;23(16):3668-75 [PMID: 15738538]
  9. J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16 [PMID: 19033573]
  10. Am J Obstet Gynecol. 1985 Apr 15;151(8):1009-15 [PMID: 3985062]
  11. Gynecol Oncol. 2009 May;113(2):163-9 [PMID: 19232699]
  12. Oncology (Williston Park). 2009 Apr 15;23(4):342-9 [PMID: 19476264]
  13. Lancet. 2009 Jan 10;373(9658):125-36 [PMID: 19070889]
  14. Lancet. 2010 Mar 6;375(9717):816-23 [PMID: 20206777]
  15. Am J Obstet Gynecol. 2000 Jun;182(6):1506-19 [PMID: 10871473]
  16. Gynecol Oncol. 2010 Mar;116(3):293-4 [PMID: 19897230]
  17. Obstet Gynecol. 1984 Jun;63(6):825-32 [PMID: 6728365]
  18. Gynecol Oncol. 1998 Aug;70(2):165-71 [PMID: 9740684]
  19. Gynecol Oncol. 2006 Nov;103(2):714-8 [PMID: 16740298]
  20. Gynecol Oncol. 2009 Nov;115(2):236-8 [PMID: 19666190]
  21. Gynecol Oncol. 2011 Apr;121(1):126-30 [PMID: 21194738]
  22. Obstet Gynecol. 2006 Dec;108(6):1375-9 [PMID: 17138769]
  23. Gynecol Oncol. 2002 Oct;87(1):112-7 [PMID: 12468351]
  24. CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300 [PMID: 20610543]
  25. Gynecol Oncol. 1998 Dec;71(3):340-3 [PMID: 9887227]
  26. Gynecol Oncol. 2006 Jul;102(1):92-7 [PMID: 16406063]
  27. Gynecol Oncol. 2008 Dec;111(3):418-24 [PMID: 18835020]
  28. J Clin Oncol. 2004 Apr 1;22(7):1234-41 [PMID: 15051771]
  29. Gynecol Oncol. 2008 Apr;109(1):11-8 [PMID: 18304622]
  30. Obstet Gynecol. 2009 Jul;114(1):7-15 [PMID: 19546752]
  31. J Surg Oncol. 1997 Jun;65(2):82-7 [PMID: 9209518]
  32. Int J Gynecol Cancer. 2010 Oct;20(11 Suppl 2):S52-4 [PMID: 20975362]
  33. Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S105-43 [PMID: 17161155]
  34. Gynecol Oncol. 2011 Aug;122(2):251-4 [PMID: 21570109]

Word Cloud

Created with Highcharts 10.0.0stagingsurgicalcancerendometrialcomprehensivehigh-riskComprehensivelymphadenectomyDespiteshiftclinical1988performanceclinicallyearly-stageremainscontroversialLow-intermediate-groupsdefinedpathologicallyHereindescriberisksbenefitsencouragedhistologieswhereasmethodtriageuseddetermineamonglow-gradeendometrioidhistologymaybenefitEndometrialPara-aorticPelvicSurgical

Similar Articles

Cited By